News and Trends 2 Oct 2024 Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C. October 2, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 10 Sep 2024 Accelerating the path to clinical filing applications with rapid toxicology material delivery Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials. September 10, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2024 Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry? Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug. August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2024 Lenacapavir: Can Gilead’s drug end the HIV pandemic? Discover more about Gilead’s lenacapavir, which recently demonstrated 100% efficacy for HIV prevention in a phase 3 trial. July 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 The 2024 drug approval list: Eight new treatments you should know about In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year. June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2024 Drugs for IgA nephropathy on the rise in the clinic As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better. May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 8 May 2024 New treatment for pulmonary hypertension: what biotech holds in store? While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease. May 8, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 19 Apr 2024The biotech investment landscape in 2024 Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.” April 19, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 15 Apr 2024 Does the FDA need to tighten its grip on drug trials in the U.S.? Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process. April 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 5 Apr 2024 How to build a career as an investigator at the FDA? Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application. April 5, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Mar 2024 Eight CAR-T cell therapy companies you should know about Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic. March 21, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2024 Is the biotech industry poised for recovery in 2024? The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery. January 8, 2024 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email